InflaRx NV
F:IF0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
InflaRx NV
F:IF0
|
DE |
|
V
|
VWF Bancorp Inc
OTC:VWFB
|
US |
|
N
|
Neodynamics AB (publ)
F:E76
|
SE |
|
L
|
Loyalty Founder Enterprise Co Ltd
TPEX:5465
|
TW |
|
S
|
Saritow Spinning Mills Ltd
KAR:SSML
|
PK |
|
S
|
Safe Mix Concrete Ltd
KAR:SMCPL
|
PK |
|
D
|
Da Hui Ltd
TPEX:5276
|
TW |
|
W
|
Wah Nobel Chemicals Ltd
KAR:WAHN
|
PK |
|
1867 Western Financial Corp
OTC:WFCL
|
US |
|
A
|
Aecon Group Inc
XMUN:2AE
|
CA |
|
P
|
Powertip Tech Corp
TPEX:6167
|
TW |
|
K
|
Kopy Goldfields AB (publ)
SWB:0KR
|
SE |
|
A-Cap Energy Ltd
F:VUT
|
AU |
|
A
|
Azion Corp
TPEX:6148
|
TW |
|
Q
|
Quadro Resources Ltd
XTSX:QRO
|
CA |
|
Interoil Exploration and Production ASA
OSE:IOX
|
NO |
|
P
|
Premier Insurance Ltd
KAR:PINL
|
PK |
|
F
|
Fredonia Mining Inc
XTSX:FRED
|
CA |
|
R
|
Rostelekom PAO
MOEX:RTKMP
|
RU |
Bankruptcy Probability
InflaRx NV's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
InflaRx NV Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DE |
|
InflaRx NV
NASDAQ:IFRX
|
304.9m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
442.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
226.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
172.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
64.9B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
InflaRx NV's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, InflaRx NV has total debt of 608.6k EUR. This includes both short-term (0 EUR) and long-term (608.6k EUR) debt.
You can find a full breakdown on its Balance Sheet.
